SN50
| Code | Size | Price |
|---|
| TAR-T12942-25mg | 25mg | £808.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃
Documents
Further Information
Bioactivity:
SN50 is a cell permeable NF-κB translocation inhibitor.
CAS:
213546-53-3
Formula:
C129H230N36O29S
Molecular Weight:
2781.5
Pathway:
NF-κb
Purity:
0.98
SMILES:
[AAVALLPAVLLALLAPVQRKRQKLMP]
Target:
NF-κB
References
1. Sun YX, et al. Therapeutic effect of SN50, an inhibitor of nuclear factor-?B, in treatment of TBI in mice. Neurol Sci. 2013 Mar;34(3):345-55.
2. Saika S, et al. Therapeutic effect of topical administration of SN50, an inhibitor of nuclear factor-kappaB, in treatment of corneal alkali burns in mice. Am J Pathol. 2005 May;166(5):1393-403.
3. Zhao K, et al. SN50 enhances the effects of LY294002 on cell death induction in gastric cancer cell line SGC7901. Arch Med Sci. 2013 Dec 30;9(6):990-8.
4. Chian CF, et al. Inhibitor of nuclear factor-?B, SN50, attenuates lipopolysaccharide-induced lung injury in an isolated and perfused rat lung model. Transl Res. 2014 Mar;163(3):211-20.